vinpocetine has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, AN; Abd-Elhaleim El Azazy, MK; Abdel Hady, MMM; Abu-Elfotuh, K; Alahmre, ATS; Ali, AA; Awny, MM; El-Sisi, AM; Elewa, MAF; Hamdan, AME; Hassan, FAM; Kamal, MM; Khalil, MG; Masoud, RAE; Othman, M; Wahid, A | 1 |
| Adeyemi, OO; Awogbindin, IO; Ishola, IO; Olajiga, AE; Olubodun-Obadun, TG | 1 |
| Al-Kuraishy, HM; Alexiou, A; Batiha, GE; Elhussieny, O; Papadakis, M; Saad, HM | 1 |
| Liang, S; Ping, Z; Xiaomu, W; Xufang, X | 1 |
1 review(s) available for vinpocetine and Parkinson Disease
| Article | Year |
|---|---|
New insights on the potential effect of vinpocetine in Parkinson's disease: one of the neglected warden and baffling topics.
Topics: Antioxidants; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Parkinson Disease; Vinca Alkaloids | 2023 |
3 other study(ies) available for vinpocetine and Parkinson Disease
| Article | Year |
|---|---|
Evaluating the neuroprotective activities of vinpocetine, punicalagin, niacin and vitamin E against behavioural and motor disabilities of manganese-induced Parkinson's disease in Sprague Dawley rats.
Topics: Acetylcholinesterase; Animals; Anti-Inflammatory Agents; Antioxidants; Glycogen Synthase Kinase 3 beta; Hydrolyzable Tannins; Manganese; Neuroprotection; Neuroprotective Agents; Niacin; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Vinca Alkaloids; Vitamin E | 2022 |
Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and α-synuclein expressions in rats.
Topics: alpha-Synuclein; Animals; Disease Models, Animal; Male; Neurodegenerative Diseases; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone | 2023 |
Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients.
Topics: Aged; Biomarkers; Case-Control Studies; Cohort Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Random Allocation; Toll-Like Receptors; Vinca Alkaloids | 2019 |